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ABSTRACT 
 
Diabetes has been concluded to be a global epidemic (Wild, Sicree, Roger, King 
& Green, 2004). By the year 2030, it is predicted that depression will become the second 
leading cause of disability worldwide (World Health Organization [WHO], 2007). The 
relationship between diabetes and depression is likely not casual. 
Those with diabetes are twice as likely to develop depression (Eaton, Armenian, 
Gallo, Pratt & Ford, 1996; Kawakami, Shimizu, Takatsuka, & Ishibashi, 1999). 
Conversely, diabetes doubles the likelihood of comorbid depression (Anderson, Clouse, 
Freedland & Lustman, 2001).  The intersection of these two devastating diseases is far 
from benign. Black, Markides and Ray (2003) found that overall mortality was increased 
five times in those with diabetes who also suffered from depression.  
There is a particularly increased burden of depression in elders with diabetes, with 
up to 30% of those over age 65 having this dual diagnosis (Anderson et al., 2001). 
Despite this high prevalence, depression is underdiagnosed in the elderly, and this group 
has a disproportionate rate of suicide. Better strategies are needed for identifying and 
treating depression in elders with concomitant diabetes. 
The purpose of this study was to assess the prevalence of depression in a 
community-dwelling population of elders with type 2 diabetes who were receiving 
diabetes self-management education (DSME) services. Specific characteristics of elders 
with diabetes were assessed in relationship to depression. A diabetes and depression 
survey instrument (DD-S) and a self-administered depression instrument (CES-D) were 
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administered to 153 elderly clients of Humphreys Diabetes Center in Boise, Idaho. 
Twenty-six completed surveys were returned by mail. 
An extremely high prevalence of depression (46%) was discovered. Most 
participants in the depression group were female (88.8%). Four participants in this group 
had not been previously diagnosed with depression, and two participants under treatment 
for depression were found to have ongoing symptoms. Depression was found to be 
significantly associated with the total number of medications participants reported taking. 
Individual medical conditions were not associated with being classified in the depression 
group nor were complications of diabetes. Depression was not associated with any 
specific demographic variable, with diabetes care compliance, or with diabetes control as 
measured by HA1c. 
It is concluded that elders with diabetes, especially females, are at very high risk 
of concomitant depression. Assessment of the total number of medications in elders with 
diabetes might help identify a subgroup at particularly high risk for depression. The 
findings from this study suggest that the use of the survey tools (DD-S in combination 
with the CES-D administered during DSME) may be an effective means of screening for 
depression in elders with diabetes. 
 
 
 
 
 
 
 
vii 
 
 
 
 
 
 
TABLE OF CONTENTS 
 
ACKNOWLEDGEMENTS  ........................................................................................ iv 
 
ABSTRACT   ............................................................................................................... v 
 
TABLE OF CONTENTS  ............................................................................................ vii 
 
LIST OF TABLES  ...................................................................................................... x 
 
LIST OF FIGURES  .................................................................................................... xi 
 
CHAPTER I   ............................................................................................................... 1 
 
 Introduction  ..................................................................................................... 1 
 
  Statement of the Problem  .................................................................... 2 
 
  Purpose and Significance of the Study  ............................................... 2 
 
  Specific Research Questions  ............................................................... 2 
 
  Limitations  .......................................................................................... 3 
 
  Delimitations  ....................................................................................... 3 
 
  Assumptions  ........................................................................................ 4 
 
  Hypotheses  .......................................................................................... 4 
 
  Definition of Terms  ............................................................................. 5 
 
CHAPTER II   ............................................................................................................... 6 
 
 Literature Review  ............................................................................................ 6 
 
  Diabetes in the Elderly  ........................................................................ 6 
 
  Depression in the Elderly  .................................................................... 7 
  The Interrelationship of Diabetes and Depression  .............................. 8 
 
 
viii 
  Treatment of Depression in Elderly Diabetes Patients  ....................... 9 
 
  Diabetes and Self-Management Education  ......................................... 11 
 
  The Present Study  ............................................................................... 12 
 
CHAPTER III  ............................................................................................................. 13 
 
 Method  ............................................................................................................ 13 
 
  Introduction  ......................................................................................... 13 
 
  Participants  .......................................................................................... 14 
 
  Study Design  ....................................................................................... 14 
 
  Measurement Tools  ............................................................................. 14 
 
  DD-S Survey Validation  ..................................................................... 15 
 
  Procedures  ........................................................................................... 15 
 
  Statistical Analysis  .............................................................................. 16 
 
CHAPTER IV  ............................................................................................................. 17 
 
 Results  ............................................................................................................. 17 
 
  Statistical Analysis  .............................................................................. 17 
 
CHAPTER V  .............................................................................................................. 32 
 
 Discussion  ....................................................................................................... 32 
 
  Limitations  .......................................................................................... 35 
 
  Conclusions  ......................................................................................... 36 
 
  Directions for Further Investigation  .................................................... 36 
 
REFERENCES  ........................................................................................................... 38 
 
APPENDIX A  ............................................................................................................. 44 
 
 DD-S, Diabetes and Depression Survey 
 
 
 
ix 
APPENDIX B  ............................................................................................................. 51 
 
 CED-S, Self-Assessment Instrument for Depression 
 
APPENDIX C  ............................................................................................................. 53 
 
 Letter of Recruitment and Consent to the Study 
 
 
 
x 
 
 
 
 
 
LIST OF TABLES 
 
Table 1. Demographic Data  .............................................................................. 18 
 
Table 2. DSME, Satisfaction, Time Since Diagnosis, and Worst Aspect 
  of Having Diabetes  ............................................................................. 20 
 
Table 3. Diabetes Care Self-Management Behaviors  ....................................... 22 
 
Table 4. Medication, Aspirin Use, Comorbidity, and Complications 
  of Diabetes  .......................................................................................... 25 
 
Table 5. Diabetes Provider Information  ............................................................ 27 
 
Table 6. Depression Data  .................................................................................. 29 
 
Table 7. Mann-Whitney Test Results for Depression versus 
  Nondepression Group  ......................................................................... 30 
 
 
 
 
 
xi 
 
 
 
 
 
LIST OF FIGURES 
 
Figure 1. Number of Medications  ...................................................................... 24 
 
Figure 2. Complications of Diabetes  .................................................................. 24 
 
Figure 3. Gender Distribution of Depression Group  .......................................... 29 
 
Figure 4. Medications and Conditions  ............................................................... 33 
 
  
1 
CHAPTER I 
Introduction 
Despite having high rates of suicide, elders with depression are underdiagnosed 
and undertreated for this disabling disorder (Centers for Disease Control and Prevention 
[CDC] 2007). There is a particularly increased burden of depression in elders with 
diabetes, with up to 30% of those over age 65 having this dual diagnosis (Anderson et al., 
2001). A depression diagnosis has been associated with worsening of diabetes control, 
increase in diabetes complications and excess mortality (Black et al., 2003). Better 
strategies are needed to screen for and treat depression elders with concomitant diabetes. 
 The elderly are less likely to seek treatment for depression due to the stigma this 
age group often associates with having a mental illness (Ayalon, Arean & Alvidrez, 
2005). In addition, the elderly have more drug side-effects and are less tolerant of 
medical therapy for depression (Borchelt, 1995) than younger patients with diabetes. Risk 
factors for depression in this population have not been well-characterized. 
 This study consisted of a diabetes survey and a depression self-test to examine the 
relationship between depression and possible risk factors for depression in elders with 
diabetes who were receiving diabetes self-management education (DSME) services at a 
community diabetes education center. DSME may represent an ideal opportunity to 
screen for depression.
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Statement of the Problem 
Elders with diabetes have a high rate of depression compared to younger persons 
with diabetes. In this particularly high-risk population, depression is underdiagnosed and 
can worsen diabetes control, complications and mortality rates. Better strategies are 
needed for identifying depression in elders with diabetes. 
 
Purpose and Significance of the Study 
The purpose of this study was to assess the prevalence of depression in a 
community-dwelling population of elders with type 2 diabetes receiving diabetes self-
management education (DSME). In addition, specific characteristics of elders with 
diabetes, which might be associated with depression or depressive symptoms, were 
assessed. For example, certain demographic variables or differences in current practice of 
diabetes self-management techniques may be associated with the prevalence of 
depression in this population. A better understanding of factors associated with 
depression in elders with diabetes could lead to improved screening and treatment for this 
disabling disorder. Treatment of depression can dramatically improve quality of life for 
those with chronic diseases such as diabetes (Jackson, DeZee & Berbano, 2004) and has 
recently been shown to decrease overall mortality in those with type 2 diabetes (Bogner, 
Morales, Post & Bruce, 2007). 
 
Specific Research Questions 
The questions addressed in this study were: 
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1. What is the prevalence of depression and/or depressive symptoms in an 
elderly community dwelling sample of patients with diabetes receiving DSME 
services? 
2. Are there particular characteristics of elders with diabetes that place them at 
higher risk for developing depression? 
3. Will depression screening during DSME identify elders with undiagnosed 
depression? 
 
Limitations 
The limitations of this study include: 
1. The study utilized a nonexperimental, cross-sectional design. 
2. A convenience sample was used. 
3. Those who attend DSME classes may have a different rate of depression than 
those who do not attend DSME classes. 
4. Diagnosis of depression and assessment of depressive symptoms were by self-
report and may underestimate the true prevalence. 
5. The visually impaired may have had trouble completing the survey and self-
test. 
6. The study survey has not been validated in previous studies. 
 
Delimitations 
There were two major delimitations of this study: 
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1. This study was delimited to community-dwelling elders aged 55 and older 
with type 2 diabetes receiving DSME services at Humphreys Diabetes Center 
(HDC) in Boise, Idaho.  
2. The variables of interest in this study were delimited to depression diagnosis 
and/or depressive symptoms, and self-reported data including: 
sociodemographic information, duration of diabetes, complications of 
diabetes, self-care behaviors, comorbidities, and medication use. 
 
Assumptions 
The following assumptions were made for this research study: 
1. Participants completed the survey and depression self-assessment tool 
accurately and honestly. 
2. Elders with diabetes receiving DSME services at HDC are representative of 
other elders in the community with diabetes. 
 
Hypotheses 
This study tested the following null hypotheses: 
1. There is not a high prevalence of depression in elders with diabetes. 
2. There are no specific characteristics associated with depression in elders with 
diabetes. 
3. Screening during DSME will not identify elders with undiagnosed depression. 
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Definition of Terms 
 Elderly: for this study, elderly will be considered to be ≥ 55 years of age. 
Type 2 diabetes: a condition of chronic carbohydrate intolerance characterized by       
 elevated blood sugar due to insulin resistance and insulin deficiency. 
Insulin: the hormone that allows sugar to be absorbed by cells in the body. 
 Microvascular: small blood vessel-related. 
 Macrovascular: large blood vessel-related. 
Self-care behaviors: blood sugar self-monitoring, foot checks (checking feet for  
signs of infection and/or injury), meal plan adherence and frequency of 
exercise. 
HA1c:  percent of hemoglobin that is glycosylated or attached to sugar. It is an  
average measurement of the level of sugar in the blood over a three-month 
period.  
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CHAPTER II 
Literature Review 
The purpose of this literature review is to examine the relationship between 
diabetes and depression in the elderly. First, the literature on diabetes in the elderly 
population will be examined. Second, studies related to depression in the elderly will be 
reviewed. Third, the connection between diabetes and depression will be established. 
Next, treatment of depression in the elderly will be outlined. Finally, DSME as an 
opportunity for depression screening will be explored. 
 
Diabetes in the Elderly 
Wild et al. (2004) reviewed the prevalence of diabetes and concluded that 
diabetes is a global epidemic. They predicted that the number of people with diabetes will 
more than double from 177 million to 366 million from the year 2000 to the year 2030. 
One in five adults over the age of 65 has diabetes, and the most significant contribution to 
the diabetes epidemic is the increasing number of people over age 65. The Centers for 
Disease Control and Prevention (CDC) (2007) support the view of diabetes as an 
epidemic and underscore the tremendous impact of this disease.  
Diabetes leads to devastating microvascular complications such as blindness, 
kidney failure and painful neuropathy, and it is the leading cause of nontraumatic 
amputations (American Diabetes Association (ADA), 2008). The macrovascular 
complications of diabetes include heart disease, stroke, and peripheral vascular disease 
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(Chau, Shumaker & Plodkowski, 2005). All of these complications are exacerbated by 
aging (Gregg & Brown, 2003). 
The prevalence of diabetes increases dramatically with age, and studies have 
confirmed the high burden of diabetes in the elderly.  For example, Selvin, Coresh, and 
Brancati (2006) analyzed data from 2,809 elderly individuals in the National Health and 
Nutrition Examination Survey and found the prevalence of diabetes in adults age 65 or 
older to be 15.3%. This is nearly twice the overall prevalence for the disease in the 
United States. In another population-based study conducted in Rotterdam, the 
Netherlands, oral glucose tolerance tests were administered to 7,439 elderly men and 
women age 55 years and older. The overall prevalence of diabetes was estimated to be 
11.3%. However, in those age 85 years and older the prevalence was 18.9%. More than 
half of those in the study who were found to have diabetes were previously undiagnosed 
(Stolk et al., 1997). With those age 85 years and older being the fastest growing segment 
of the American population (Hobbs, 2001), the diabetes epidemic is likely to rapidly 
intensify. 
 
Depression in the Elderly 
Depression is another common affliction of modern society. By the year 2030, it 
will become the second leading cause of disability worldwide (WHO, 2007). It engenders 
high costs to both the individual in terms of anguish and decreased productivity and 
creates a tremendous economic and social loss to society (Simon, 2003). Depression is 
underdiagnosed in the elderly, and this group has a disproportionate rate of suicide 
(National Institute of Mental Health [NIMH], 2007). Spousal death and chronic illness 
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are the two most significant risk factors for the development of geriatric depression 
(Shoevers et al., 2006). Other previously identified risk factors include prior depression, 
sleep disturbance, disability, and female gender (Cole & Dendukuri, 2003). Risk factors 
for depression in elders with diabetes have not specifically been studied. 
 
The Interrelationship of Diabetes and Depression 
The relationship between diabetes and depression is likely not casual. Those with 
depression are twice as likely to develop diabetes (Eaton et al., 1996; Kawakami et al., 
1999). Conversely, diabetes doubles the likelihood of comorbid depression from 15% to 
approximately 30%, according to a comprehensive meta-analysis by Anderson et al. 
(2001). Finkelstein et al. (2003), in a retrospective study of over two million Medicare 
claimants age 65 and older, found that there was a significantly greater likelihood (OR 
1.58±0.05) of depression in those with diabetes than in those who did not have the 
disease. A study of depressive symptoms in rural elders in North Carolina with diabetes 
revealed a high risk for depressive symptoms, regardless of ethnicity (Bell et al., 2005). 
When diabetes and depression intersect, the effect on adverse events appears to be 
highly synergistic. Black et al. (2003) examined longitudinal data from the Hispanic 
Established Population for the Epidemiologic Study of the Elderly (EPESE) survey and 
found that the risk of microvascular complications of diabetes increase eleven-fold. In 
addition, macrovascular complications double, and overall mortality increases five times 
in those with diabetes who also suffer from depression. Increased mortality was also 
strongly associated with both minor and major depression in a large Health Maintenance 
Organization (HMO) study of 4,154 patients with type 2 diabetes (Katon et al., 2005). 
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DeGroot, Anderson, Freedland, Clouse, and Lustman (2001) conducted a meta-analysis 
of 27 studies linking diabetes and depression. A significant association was found 
between depression and diabetes complications. In addition, those with both diabetes and 
depression were less compliant with treatment and found to have 86% higher health costs 
than those with diabetes alone (Ciechanowski, Katon & Russo, 2000).   
The dual presence of diabetes and depression has a dramatic effect on quality of 
life. More than 3,000 adults in Australia were assessed with the Short Form Health-
Related Quality of Life Questionnaire (SF-36). Those with diabetes and depression 
experienced a severe impact, with a large effect size, on every dimension of the SF-36 as 
compared to those with diabetes who were not depressed (Goldney, Fisher, Phillips & 
Wilson, 2004). Likewise, an SF-36 study in an elderly Greek population with diabetes 
found that comorbidity, such as concomitant depression, was a significant predictor of 
lower health-related quality of life (Papadopoulos, Kontodimopoulos, Frydas, 
Ikonomakis & Niakas, 2007). Several instruments have been developed to assess 
diabetes-specific quality of life, and impact on psychological functioning is considered 
central to this assessment (Polonsky, 2000). 
 
Treatment of Depression in Elderly Diabetes Patients 
Even when depression is properly diagnosed, treatment of depression in the elder 
with diabetes is complicated. Physiological changes associated with aging make the 
elderly more prone to medication side effects and drug-drug interactions (Hitner & 
Nagle, 2005). Ayalon, Arean, and Alvidrez (2005) found significant barriers to treatment 
of depression in the elderly that included not only side effects of the medications, but also 
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fear of stigma of being treated for depression. Cognitive impairment was associated with 
unintentional nonadherence to medication.  
Another issue facing elderly persons is the fact that type 2 diabetes has significant 
comorbidity with other medical conditions such as hypertension and hyperlipidemia 
(Robbins, Webb & Sciamanna, 2005). Almost all patients with type 2 diabetes are 
prescribed multiple medications, and adverse drug interaction becomes an increasing 
concern (Borchelt, 1995). Patients may not understand that the antidepressant is just as 
important as their other medications. Cost is also a huge barrier to treatment of 
depression and leads to poor health outcomes (Mojtabal & Olfson, 2003).                               
Standard antidepressants have been studied in the treatment of depression in those 
with diabetes. Nortriptyline, an older, less expensive antidepressant was evaluated in a 
double-blind, placebo-controlled trial of 68 patients (Lustman et al., 1997). This drug was 
found to be effective for treating depression; however, it had a negative effect on 
glycemic control. In addition, nortriptyline, and the older antidepressant drugs in general, 
can have substantive anticholinergic side effects (Hitner & Nagle, 2005). Anticholinergic 
action has recently been associated with cognitive decline in a longitudinal cohort study 
of 372 participants over age 60 (Ancelin et al., 2006). This is an unacceptable outcome of 
the treatment of geriatric depression. 
Newer antidepressant agents, such as the selective serotonin reuptake inhibitor 
(SSRI) fluoxetine, have good efficacy and are less anticholinergic than the older agents 
(Lustman, Freedland, Griffith & Clouse, 2000). They do not worsen glycemic control; 
however, they are much more costly. No antidepressant drug trials have specifically 
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evaluated elders with diabetes and depression, though fluoxetine has been approved for 
use in the elderly population. 
Second generation antipsychotics are being used more and more frequently as 
adjunctive treatment in both unipolar and bipolar depression. Koller, Cross, Doraiswamy, 
and Schneider (2003) studied the hyperglycemic effect of the drug respiradone, a second-
generation antipsychotic agent. They reported that respiradone and several other 
antipsychotic drugs can cause not only hyperglycemia, but can cause the emergence of 
diabetes. Citrome et al. (2007) reviewed 25 studies of antipsychotic agents and concluded 
that the second generation agents are not significantly less of a risk than first-generation 
antipsychotic agents. Clearly, care must be taken when prescribing antidepressant and 
antipsychotic medication to elders with diabetes. 
 
Diabetes Self-Management Education  
 DSME is the foundation of treatment for diabetes and should occur as close to the 
diagnosis as possible (Mensing et al., 2007).  DSME has been shown to improve 
glycemic control as well as decrease the chronic complications of diabetes (ADA, 2008).            
Formal DSME usually consists of a week- long program from certified diabetes educators 
(CDE) at an American Diabetes Association (ADA) certified center. ADA certification is 
often required for insurance reimbursement (Powell, Glover, Probst & Laditka, 2005).  
DSME provides an understanding of the pathophysiology of diabetes in lay terms, 
teaches patients how to test their own blood sugar, and also highlights the importance of 
care of their highly vulnerable feet. Healthy eating, exercise and weight management are 
also stressed. Advanced education teaches insulin adjustment and carbohydrate counting. 
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Despite the otherwise comprehensive nature of DSME, it has not traditionally included 
screening for depression. DSME may be an ideal opportunity to assess depressive 
symptomatology. 
 
The Present Study 
The present study assessed a community-dwelling population of elders with 
diabetes using a survey developed for this project. The presence of depressive symptoms 
was evaluated using the CES-D, a widely used and validated measure (Radloff, 1977). 
The study assessed self-reported demographic variables, attitudes about diabetes and 
control, and complications of diabetes. In addition the presence of comorbidities, 
medication use and self-care behaviors in relation to depression diagnosis and symptoms 
were also evaluated. 
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CHAPTER III 
Method 
Introduction 
 The tremendous burden of diabetes in the elderly population has been 
documented (CDC, 2007; Selvin et al., 2006; Stolk et al., 1997), and the connection 
between diabetes and depression has been well-established (Anderson et al., 2001; Eaton 
et al., 1996, Finkelstein et al., 2003). Many elders with diabetes and depression remain 
undiagnosed and untreated, partly because current screening is inadequate (NIMH, 2007). 
Diabetes Self-Management Education (DSME) is the foundation of diabetes therapy 
(Mensing et al., 2007) and has been shown to decrease diabetes complications as well as 
to increase well-being (Rubin, Peyrot & Saudek, 1989). DSME may be the ideal occasion 
to assess elders with diabetes for depression. 
 
Participants 
 The sampling frame for this study was a nonrandom convenience sample of adults 
aged 55 or older receiving DSME services at Humphreys Diabetes Center (HDC) in 
Boise, Idaho. Permission was obtained from the research committee of HDC to conduct 
the study at this facility. 
   
 
  
14 
Study Design 
This is a nonexperimental, cross-sectional study. A cross-sectional approach  
is appropriate for measuring prevalence or risk factors of a disease in a population and 
when no study intervention is intended. 
 
Measurement Tools 
 The study utilized a diabetes and depression survey instrument, the DD-S 
(Appendix A).  This instrument was constructed as the final project for the fall 2007 
graduate seminar, Survey and Community-Based Research, at Boise State University.  
DSME stresses the importance of self-care. Several items related to compliance 
with diabetes self-care recommendations were queried with the DD-S. These included 
frequency of: 1) blood sugar testing; 2) following a meal plan; 3) foot inspection; and 4) 
exercise. Responses to these items were combined to create a compliance score for 
purposes of analysis. This allowed each respondent to receive a single self-care 
composite compliance score with a maximum of 16 points. Other constructs evaluated 
with the DD-S included depression diagnosis and self-reported data including: 
sociodemographic information, duration of diabetes, complications of diabetes, self-care 
behaviors, comorbidities, and medication use. 
In addition to completing the DD-S, each participant was asked to fill out the 
CES-D (Appendix B), a self-administered depression instrument. The CES-D has been 
widely used and validated and has a coefficient alpha of .85 (Radloff, 1977). 
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DD-S Survey Validation 
Face and content validity of this survey was assessed by a number of health care 
professionals. With respect to construct validity, a high prevalence of depression was 
hypothesized for the study population, and the instrument was evaluated for ability to 
confirm this hypothesis. In addition, three separate questions on the survey associated 
with depression diagnosis were assessed for correlation. 
 
Procedures 
The study was approved by the Institutional Review Board at Boise State 
University. 
The principal investigator is a previous Medical Director with longstanding 
relationships with HDC staff. Contact was made with Judy Davis, R.N., program director 
at HDC, and a copy of the study proposal was provided. After the protocol was approved 
by the HDC Research Committee, survey packets were delivered to Ms. Davis. Ms. 
Davis educated other HDC educators about the study and distributed survey packets to 
DSME classes and to individual nurses and dieticians. Nurses and dieticians conducting   
classes and individual consultations administered the survey packets to HDC clients. 
Participants had type 2 diabetes, were aged 55 and older, and were receiving DSME 
services. There were two distribution periods, the first from September 18 to October 5th 
and the second from January 5th to the 31st. Study participation was offered to all age-
appropriate clients during the two distribution periods. Surveys were administered at both 
the Boise and Meridian HDC locations. 
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The packet contained a recruitment/consent letter (Appendix C), a diabetes and 
depression survey (DD-S – Appendix A) and a depression self-assessment instrument 
(CES-D – Appendix B). All information obtained was confidential and identified by 
protocol and participant numbers only. Study materials were kept in a cabinet in the 
Health Sciences Riverside Building, Room 122A at Boise State University for the 
duration of the study. 
 
Statistical Analyses 
 The prevalence of depression was assessed via one of three methods: 1) by 
frequency counts of those who self-reported a depression diagnosis; 2) those who self-
reported taking an antidepressant on the medication list; and 3) those with a score of 16 
or above on the CES-D. Participants from these three categories were combined into a 
depression group for comparison to others in the study (the nondepression group). 
 A Mann Whitney test  was used to compare the depression vs. nondepression 
groups on a number of variables such as age, score on the composite compliance variable, 
score on the CES-D, HA1c test score, number of medications and number of conditions.  
 A chi square test was used to assess the relationship between depression group 
and other variables in the study such as gender, specific conditions and complications of 
diabetes.  
All data was analyzed using the Statistical Package for the Social Sciences 
(SPSS). Statistical tests were two-tailed maintaining an overall α = .05 level of 
significance.  
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CHAPTER IV 
Results 
One hundred and fifty-three surveys were distributed to clients receiving diabetes 
self-management education (DSME) at Humphreys Diabetes Center (HDC) in Boise, 
Idaho. Twenty-six surveys were returned by mail for a 17% response rate. 
This survey was presented to several health professionals and judged to have good face 
and content validity. With respect to construct validity, a high prevalence of depression 
was hypothesized for the study population, and the instrument confirmed this high 
prevalence. In addition, there was complete correlation between self-reported diagnosis 
of depression, reported treatments for depression and listed antidepressant medications. 
 
Statistical Analyses 
Of the 18 participants reporting their gender, 12 (67%) were female and 6 (33%) 
were male. The mean age of the nineteen participants who reported their age was 66 (SD 
= 4.98) with a range of 58 to 77. All but one participant reported their ethnicity, marriage 
and financial status.  All 25 (100%) of these were white. With respect to socioeconomic 
status (SES), 17 (68%) reported their financial status as comfortable or very comfortable, 
five (20%) reported just getting by and three (12%) reported not being able to make ends 
meet. Twenty (80%) of participants were married. Of the 24 who reported information 
about insurance status only one participant (4%) had no insurance. 
 
  
18 
Table 1.  
Demographic Data 
 
Variables 
 
Total number of participants 
 
(% of total) 
 
 
Gender (N = 18) 
Female 
Male 
 
 
12 (67%) 
6 (33%) 
Age (N = 19) 
<65 years of age 
65 and over 
 
9 (47%) 
10 (53%) 
Ethnicity (N = 25) 
White 
African American 
American Indian 
Hispanic 
Asian/Pacific Islander 
Other 
 
25 (100%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
Marital Status (N = 25) 
Married or Partnered 
Divorced 
Separated 
Widowed 
 
20 (80%) 
2 (8%) 
0 (0%) 
3 (12%) 
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Variables 
 
Total number of participants 
 
(% of total) 
 
Single 
Other 
Financial Status (N = 25) 
Very Comfortable 
Comfortable 
Just Getting By 
Can’t Make Ends Meet 
0 (0%) 
0 (0%) 
 
1 (4%) 
16 (64%) 
5 (20%) 
3 (12%) 
Insurance Status (N = 24) 
Medicare Only 
Medicare/Medigap 
Medicaid 
No Insurance 
Private Insurance 
Veterans Administration 
Other 
 
2 (8%) 
12 (50%) 
1 (4%) 
0 (0%) 
8 (34%) 
0 (0%) 
1 (4%) 
 
 Twenty-four (92%) participants were enrolled in a formal DSME program, and of 
these, 20 (80%) were satisfied with the education provided. Eleven (42%) participants 
had met with the nurse educator or dietician separately and nine (82%) of these were 
satisfied with their care. Of the 11 (42%) who received brief education in the doctor’s 
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office, seven (64%) were satisfied. One participant reported having had no diabetes 
education. 
Seventeen (65%) of the participants were diagnosed within one year of receiving 
DSME services. The mean years duration of diabetes was 4.69 (SD = 7.51) with a range 
from less than one year to 34 years. Fifteen (58%) reported that fear of medical 
complications was the worst aspect of having diabetes, while seven (27%) were most 
bothered by having to follow a meal plan. Only one (4%) participant cited cost as the 
worst aspect of having diabetes. 
 
Table 2.  
DSME, Satisfaction, Time Since Diagnosis, and Worst Aspect of Having Diabetes  
 
Variables 
 
Total number of participants 
 
(% of total) 
 
DSME (N = 26) 
Formal DSME 
Satisfied 
Not Satisfied 
No response 
Nurse or Dietician 
Satisfied 
Not Satisfied 
Brief doctor/nurse office Ed. 
 
 
24 (92%) 
20 (83%) 
1 (4%) 
3 (13%) 
11 (42%) 
9 (82%) 
2 (18%) 
11 (42%) 
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Variables 
 
Total number of participants 
 
(% of total) 
Satisfied 
Not Satisfied 
No Diabetes Education 
7 (64%) 
4 (36%) 
1 (4%) 
Years since diagnosis (N = 25) 
<5 years 
5 years or longer 
 
18 (72%) 
7 (28%) 
Worst aspect of diabetes (N = 26) 
Fear of medical complications 
Following a meal plan 
Cost 
 
Other 
 
 
15 (58%) 
7 (27%) 
1 (4%) 
3 (11%) 
 
 Diabetes management self-care behaviors were evaluated as presented in Table 3. 
Almost two-thirds of the participants (65%) reported testing their blood sugar at home at 
least two or more times per day. Eight (31%) participants checked their feet on a daily 
basis and 10 (38%) checked at least two or more times per week. Eleven (42%) 
participants followed a meal plan on a daily basis, while seven (27%) followed two or 
more times per week. Exercise frequency was daily for six (23%) of the participants and 
two or more times per week for 11 (42%). One participant was unable to exercise due to 
severe neuropathy. 
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Twenty participants reported a HA1c level and all testing was within the last six 
months. The average was 7.7% (SD = 2.8%). Six (23%) either did not know what a HA1c 
was or did not respond to the question. 
 
Table 3. 
Diabetes Care Self-Management Behaviors 
 
 
Variables 
 
Total number of participants 
 
(% of total) 
  
Blood Glucose Testing (N = 26) 
 
Never 
Sometimes 
Daily 
Two or more times per day 
Can’t afford test strips 
 
 
0 (0%) 
2 (8%) 
6 (23%) 
17 (65%) 
1 (4%) 
Checking feet (N = 26) 
Never 
Sometimes 
Two or more times per week 
Daily 
 
1 (4%) 
7 (27%) 
10 (38%) 
8 (31%) 
Follow Meal Plan (N = 26) 
Never 
Sometimes 
 
1 (4%) 
6 (23%) 
  
23 
 
Variables 
 
Total number of participants 
 
(% of total) 
Two or more times per week 
Daily 
Other 
7 (27%) 
11 (42%) 
1 (4%) 
Exercise (N = 26) 
Never 
Sometimes 
Two or more times per week 
Daily 
Other 
 
2 (8%) 
5 (19%) 
11 (42%) 
6 (23%) 
2 (8%) 
Hemoglobin A1c (N = 21) 
Mean HA1c (SD) Range 
Last HA1c test (N = 26) 
Within 1 month 
Within 3 months 
Within 6 months 
 
7.68 (2.81) (5.90-18.40) 
 
(61%) 
9 (35%) 
1 (4%) 
 
 Eight (31%) participants reported taking 0-4 medications, 11 (42%) reported 
taking, 5-8, and seven (27%) reported taking 9-12 medications as illustrated in Figure 1. 
Twelve (46%) participants reported daily aspirin use. 
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  Figure 1. Number of Medications 
 
A wide variety of concomitant illnesses were reported by the participants. These 
included high cholesterol (18; 69%), high blood pressure (18; 69%), obesity (13; 50%), 
depression (9; 35%), other medical problems (7; 27%) and heart problems (5; 19%). 
Complications of diabetes were asked about and are illustrated in Figure 2. Six 
(23%) participants reported eye complications of diabetes, while 11 (42%) reported nerve 
problems.  Only one (4%) participant reported heart problems and two (8%) reported 
circulation problems. No participant reported kidney problems. 
 
 
         Figure 2. Complications of Diabetes 
31% 
42% 
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Number of Medications 
0 to 4 5 to 8 9 to 12 
0% 
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20% 
30% 
40% 
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Eye Nerve Heart Circulation Kidney 
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Table 4.  
Medication, Aspirin Use, Comorbidity, and Complications of Diabetes 
 
Variables 
 
Total number of participants 
 
(% of total) 
 
 
Number of Medications (N = 26) 
0-4 
5-8 
9-12 
 
 
8 (31%) 
 
11 (42%) 
7 (27%) 
Other Medical Problems (N = 26) 
High Cholesterol 
High Blood Pressure 
Obesity 
Depression 
Heart Problems 
Cancer 
Arthritis 
Lung Problems 
Anxiety 
Other 
 
18 (69%) 
18 (69%) 
13 (50%) 
9 (35%) 
5 (19%) 
4 (15%) 
4 (15%) 
3 (12%) 
2 (8%) 
7 (27%) 
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Variables 
 
Total number of participants 
 
(% of total) 
 
Aspirin Use (N = 26) 
Daily aspirin 
No aspirin 
 
12 (46%) 
14 (54%) 
Complications of Diabetes 
(N = 26) 
 
Nerve Problems 
Eye Problems 
Kidney Problems 
Heart Problems  
Circulation Problems 
Other 
None 
 
11 (42%) 
6 (23%) 
0 (0%) 
1 (4%) 
2 (8%) 
1 (4%) 
5 (19%) 
 
 
Table 5 reveals that only two (8%) participants were seeing an Endocrinologist 
for their diabetes care, whereas most, or 18 (68%), were being cared for by their general 
doctor. Two (8%) participants were seeing a nurse practitioner and two (8%) had no 
current diabetes provider. Of the two that reported other sources of care, one (4%) 
reported that Humphreys Diabetes Center was his or her diabetes provider. 
Eight (31%) participants reported that their provider was very informed about diabetes, 
six (23%) reported their provider was somewhat informed, and nine (34%) did not know.  
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Table 5.  
Diabetes Provider Information 
 
Variables 
 
Total number of participants 
(% of total) 
 
 
Diabetes Provider (N = 26) 
Specialist (Endocrinologist) 
General Physician 
Nurse Practitioner 
No Current Diabetes Provider 
Other 
 
 
2 (18%) 
6 (33%) 
2 (8%) 
2 (8%) 
7 (27%) 
Provider Knowledge 
Very Informed 
Somewhat Informed 
I Don’t Know 
Somewhat Uninformed 
Very Uninformed 
No Provider 
 
8 (31%) 
6 (23%) 
9 (34%) 
1 (4%) 
0 (0%) 
2 (8%) 
 
Antidepressant medications reported by participants included fluoxetine, 
sertraline, duloxetine and trazadone. None of the participants reported taking third 
generation antipsychotic medication, nor were anticholinergic medications listed. No 
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participant in the study reported taking a medication for depression known to cause or 
worsen diabetes. 
Eight participants reported that they had been diagnosed with depression, and of 
those, six (75%) were receiving medication therapy, one (12.5%) was receiving 
psychotherapy, and one (12.5%) was being treated with both modalities. Of those being 
treated for depression, two (25%) scored above 16 on the CES-D. One of those 
participants reported taking fluoxetine, and the other was not on an antidepressant. In 
addition, four (22%) who had not previously been diagnosed with depression also had 
significant depressive symptomatology on the CED-S. A total of 12 (46%) participants 
either had a previous diagnosis of depression or a positive score on the CES-D, and these 
12 comprised the depression group for purposes of analysis. 
Among the 18 participants who reported their gender, nine were classified in the 
depression group. Of these, eight (88.8%) were women. Women were thus found to be 
significantly more likely to be depressed or have a diagnosis of depression than men, 
χ2(1, N = 18) = 4.27, p ≤ .05.  
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            Figure 3. Gender Distribution of Depression Group 
 
Table 6.  
Depression Data 
 
Variables 
 
Total number of participants 
 
(% of total) 
 
Diagnosis of depression (N = 26) 
 
Yes 
 
No 
 
 
 
 
8 (31%) 
 
18 (69%) 
Treated for depression (N = 8) 
Normal CES-D 
Depressive CES-D 
 
6 (75%) 
2 (25%) 
Therapies for Depression (N = 8)  
11.20% 
88.80% 
Gender Distribution of  
Depressed Group 
Male 
Female 
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Variables 
 
Total number of participants 
 
(% of total) 
Medication 
Psychotherapy 
Medication and Psychotherapy 
6 (74%) 
1 (13%) 
1 (13%) 
No depression diagnosis (N = 18) 
Normal CES-D 
Depressive CES-D 
 
14 (78%) 
4 (22%) 
 
Mann-Whitney tests were performed comparing the depression and nondepression 
groups with respect to age, HA1c score, CES-D score, composite compliance score, 
number of conditions, number of medications and years with diabetes. 
 
Table 7 
Mann-Whitney Test Results for Depression versus Nondepression Group 
 Depression Nondepression Mann-Whitney 
Variable 
 
N Mean Median N Mean Median z p 
Medications 12 8.33 9.5 14 3.71 3.5 -3.16 
 
0.002 
 
CES-D 11 15.36 17 13 4.54 3 -3.57 0.001 
Conditions 12 4.42 5.5 14 2.5 2 -1.91 0.056 
HA1c 8 6.95 6.85 13 8.13 7.2 -0.29 0.772 
Compliance 12 12.08 13 14 12.71 14 -0.73 0.466 
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 Number of conditions, HA1c value, compliance score, age and years with 
diabetes were not significantly different between depression and nondepression groups. 
The self-reported number of medications were significantly higher in the depression than 
nondepression group (z =  -3.16, p = .002). Number of medications and number of 
conditions were highly correlated r(26) = .57 p ≤ .01. Score on the CES-D was 
significantly higher in the depression compared to the nondepression group (z = -3.57, p 
= .001). Those with complications of diabetes were not found to have had a significantly 
longer duration of diagnosed diabetes or a difference in age. 
Chi square analysis revealed that those in the depression group were no more 
likely to have high cholesterol, high blood pressure, obesity, heart problems, lung 
problems, cancer or anxiety, compared to those in the nondepression group. Similarly, 
none of the complications of diabetes such as eye, nerve, heart or circulation problems 
were more frequent in the depression group. 
There was no difference between depression versus nondepression groups with 
respect to marital status or fear of medical complications from diabetes. Although twice 
as many in the nondepression group (64.7%) compared to the depression group (35.3%) 
were financially comfortable, financial status was not predictive of depression group. 
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CHAPTER V 
Discussion 
 The overall rate of response to this survey was low, but approximates typical rates 
for mail-in surveys (Neutens & Rubinson, 2002). There is no reason to believe there was 
response bias to this survey. Although the stigma of depression may have led some 
clients not to participate, it is speculative whether those with or without depression would 
have been more or less likely to participate. 
 The most important finding of this study is the extremely high prevalence of 
depression in this group of community dwelling elders with diabetes. Nearly half (46%) 
of study participants had a diagnosis of depression and/or scored positively on the CES-
D. Though prevalence data is not available specifically on elder adults with diabetes, 
previous estimates of depression in all adults with diabetes is stated to be about 30% 
(Anderson et al., 2001). Twenty-five percent of those with a positive CES-D in this study 
were previously undiagnosed with depression, and 25% of those under treatment for 
depression were still symptomatic. Clearly, better screening for depression is needed in 
elders with diabetes, and when depression is treated, better follow-up is needed for this 
insidious condition. 
 No study participant was found to be taking a medication for depression that is known to 
cause or worsen type 2 diabetes. All antidepressants used by participants in this study 
were in the class of selective serotonin reuptake inhibitors. This class of antidepressants 
is usually effective and well-tolerated in the elderly (Lustman et al., 2000).  
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A further important finding from this study is that depression in the elder with 
diabetes is significantly related to the number of medications taken. As number of 
medications is highly correlated with number of medical conditions, number of 
medications alone may be a simple measure with which to estimate burden of disease. 
Number of medications as a factor associated with depression in diabetes has not been 
previously reported and may be useful in identifying a high-risk subgroup. 
 
 
  Figure 4. Medications and Conditions 
 
No specific medical condition was associated with being in the depression group, 
nor was any specific complication of diabetes found with significantly greater frequency 
in this group. In previous studies heart disease has been so highly associated with 
depression that screening for depression is now recommended for all those with heart 
disease (Lichtman et al., 2008). Only five participants in this study reported heart disease, 
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and failure to find an association with depression is most likely related to such a small 
sample size. 
Obesity has previously been shown to increase the risk of adult depression (Simon 
et al., 2006). Half of the people in the study reported being obese; however, obesity was 
no more common in the depression group than the nondepression group. It is possible 
that elders differ from other adults with respect to this variable and further study of this 
issue seems warranted. 
 Female gender is a well-known risk factor for depression (Cole & Dendukuri, 
2003). This study suggests that the depression risk is even higher in the elderly female 
with diabetes than in other adult females. Previous studies have found a 2:1 female to 
male prevalence of depression (CDC, 2007); however, in this study, almost all of those in 
the depression group were female. Additionally, the two participants with a previous 
diagnosis of depression who were still symptomatic were both female. The reasons for 
gender differences in depression are not known; however, this knowledge may help 
inform future depression screening and treatment efforts. 
 This study did not show a relationship between depression and diabetes care 
compliance behaviors, as has previously been reported (Ciechanowski, Katon & Russo, 
2000). It is likely that this is an artifact of participants being studied at a diabetes 
education center, where compliance and control are strongly emphasized. It may also 
relate to the relatively recent onset of diabetes diagnosis in this sample, as self-care 
behaviors may wane over time. 
 Similarly, diabetes control, as measured by HA1c, was not worse in the 
depression group than in the nondepression group. The overall average HA1c of all study 
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participants of 7.68 is remarkably low. Despite this excellent control, several participants 
did report complications of diabetes. It may be that participants had higher glucose levels 
at other times in the course of their illness, even prior to diagnosis. It is known that half 
of those with diabetes in this country remain undiagnosed, and many with diabetes may 
have the disease for up to 15 years before a clinical diagnosis is made (CDC, 2007). 
 Of no relation to depression, but of definite concern, is that only 46% of 
participants were taking daily aspirin. Those with diabetes are considered to have as high 
a risk for coronary disease as those who have had a previous myocardial infarction, and it 
recommended that all patients with diabetes take daily aspirin prophylaxis (ADA, 2008). 
This simple intervention could be life-saving for elders with diabetes. Almost all 
participants in this study were being followed for their diabetes in the primary care 
setting. It would seem greater education of primary care physicians regarding this issue is 
warranted. 
 
Limitations 
 The primary limitation of this study is the small sample size. Failure to provide 
training and/or a written script to diabetes educators responsible for recruitment was a 
definite oversight and may have fostered low participation. In addition, the homogeneity 
of the participants with respect to ethnicity and financial status makes the results of the 
study less generalizable. Elders with diabetes receiving DSME services may be different 
in other ways from elders with diabetes in the community. 
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Conclusions 
The high prevalence of depression found in this study lends support for regular 
depression screening of all elders with diabetes. The findings from this study further 
suggest that females and those with high comorbidity are at particular risk. These 
subgroups may need to be screened more often. In addition, this study underscores the 
need for regular assessment of the effectiveness of depression treatment.   
The goal of DSME is to enable patients to control, care for and cope with 
diabetes. Untreated depression thwarts all of these efforts (Black, Markides, & Ray, 
2003) and may make DSME much less effective. Fortunately, patients are often referred 
for DSME early after the diagnosis of diabetes, as was seen in this study. These factors 
indicate that DSME is an ideal occasion to screen for depression. The DD-S in 
combination with the CES-D, administered during DSME, was a very effective way to 
screen for depression in elders with diabetes. Such screening would promote early 
detection and treatment of depression. This could lead to improved quality of life 
(Jackson, DeZee & Berbano, 2004) and better outcomes for elders with diabetes (Bogner, 
Morales, Post & Bruce, 2007). 
 
Directions for Further Investigation 
 Further validation of the DD-S survey instrument is needed. Utilization of the 
survey in a clinic setting with comparison to the medical record would provide criterion 
validity. Comparison of reported HA1c to that measured during DSME would be 
similarly informative.  
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 To confirm that the results of this study can be generalized, especially the high 
prevalence of depression, it is important to study a community sample of elders with 
diabetes who are not receiving DSME services. 
 With a larger sample size, differences between the depression and nondepression 
group with respect to compliance score, obesity, and heart disease may be revealed. 
Power analysis reveals that 74 more participants would be needed to more fully evaluate 
these issues. 
Key stakeholders such as the HDC Research Committee, Board of Directors and 
staff will be presented the results of this study.  The most exciting possibility for further 
research would be to incorporate the study surveys into regular DSME programs for an 
extended study period. Stakeholder counsel and support will be invaluable to the next 
phase of study. 
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APPENDIX A 
DD-S, Diabetes and Depression Survey 
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DD-S 
Q1. When were you diagnosed with diabetes?   _____year 
Q2. What is the worst aspect of having diabetes?  
(Please circle your answer) 
1. Fear of complications 
2. Following a meal plan 
3. Cost of medical care and supplies 
4. Other________________________ 
 
Q3. What sort of diabetes education have you completed? 
(Circle the one answer that most closely describes your experience) 
1. Formal program or classes at a diabetes center 
2. Met with the nurse educator and/or dietician 
separately 
3. Brief education from my doctor and/or his or her 
nurse 
4. None 
 
Q4. How satisfied or dissatisfied were you with your educational 
experience? 
    Very                   Very 
      Dissatisfied                    Satisfied 
          1                    2          3      4               5 
 
For the next four questions, please refer to your habits over the last 
month: 
Q5. Do you test your blood sugar at home? 
1. Never 
2. Sometimes 
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3. Daily 
4. Two times per day or more 
5. Other___________________ 
 
Q6. Do you check your feet? 
1. Never 
2. Sometimes 
3. Twice a week 
4. Daily 
5. Other________________ 
 
Q7. Do you follow a meal plan? 
1. Never 
2. Sometimes 
3. Twice a week 
4. Daily 
5. Other________________ 
 
Q8. Do you exercise? 
1. Never 
2. Sometimes 
3. Twice a week 
4. Daily 
5. Other________________ 
 
 
 
Q9. Whom do you see for your diabetes care? 
1. Diabetes Specialist (Endocrinologist) 
2. General Doctor (Internist or Family Practitioner) 
3. Nurse Practitioner or Physician Assistant 
4. Other_______________________________ 
 
Q10. How satisfied or dissatisfied are you with your diabetes care? 
      Very               Very 
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         Dissatisfied                         Satisfied 
          1                    2          3              4              5 
Q11. When was your last A1C test?___Month___Year__Do not know 
Q12. What was your last A1C value _______ %________Do not know 
Q13. Please list your medications: 
_____________________ ______________________  
_____________________ ______________________    
_____________________ ______________________ 
_____________________ ______________________  
_____________________         ______________________ 
_____________________         ______________________ 
Q14. Do you take an aspirin every day?               ____ Yes____No 
 
 
 
Q15. Do you have any complications of your diabetes? Yes     No 
Eye problems (cataracts, glaucoma, blindness)      1        2 
Nerve problems (burning, numbness, tingling)           1        2 
Kidney problems (dialysis, transplant)                   1           2                     
Heart problems (angina, heart attack)       1        2 
Circulation problems (stroke, loss of limb)      1          2 
Other________________________________ 
 
Now there will be just a few questions about depression: 
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Q16. There are many challenges to living with diabetes. Have you 
ever been diagnosed with depression?                 
 ______Yes______No 
 If No, skip to Question 18. 
Q17. What treatment have you had for depression? 
1. No treatment 
2. Psychotherapy 
3. Medication 
4. Psychotherapy and Medication 
 
 
 
 
The next five questions ask some personal information. All responses 
will be kept confidential: 
 
Q18. When were you born?   _______Month_______Year 
Q19. What is your gender? 
1. Male 
2. Female 
 
Q20. What sort of insurance do you have? 
1. Medicare only 
2. Medicare and Medigap or other supplement 
3. Medicaid 
4. No insurance 
 
Q21. Please rate your financial status: 
1. Comfortable 
2. Very Comfortable 
3. Just getting by 
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4. Can’t make ends meet 
 
Q22. Which of the following best describes your racial or ethnic 
identification? 
1. White (Caucasian) 
2. African American 
3. Hispanic 
4. Native American/American Indian 
5. Asian or Pacific Islander 
6. Other (please specify)________________________ 
Q25. What is your marital status? 
1. Married 
2. Divorced 
3. Separated 
4. Widowed 
5. Never Married or Partnered 
6. Single 
7. Partnered  
 
 
Please make any further comments you may have about the topics in 
this survey: 
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Thank you very much for participating in this important survey. All 
of your answers will remain anonymous and will be used for 
research purposes only.
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APPENDIX B 
CES-D, Self-Assessment Instrument for Depression 
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The CES-D 
 
There are restrictions to copying this instrument. 
It may be found at: http://www.chcr.brown.edu/pcoc/cesdscale.pdf 
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APPENDIX C 
Letter of Recruitment and Consent to the Study 
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January 5, 2009 
Dear Volunteer, 
A group of faculty and student researchers at Boise State University are conducting a 
study of type 2 diabetes. Specifically, we are interested in knowing more about the 
diabetes self-management education you have received. 
Attached to this letter you will find two documents. The first is a diabetes survey, the 
DD-S. This survey asks questions about how long you have had diabetes, diabetes 
education, complications and control. There are also a few questions related to 
depression. This survey also asks demographic information. Due to the make-up of 
Idaho’s population, the combined answers to these questions may make an individual 
person identifiable. We will make every effort to protect your confidentiality. However, 
if you are uncomfortable answering any of these questions, you may leave them blank 
and complete the rest of the survey. 
The second document, the CES-D, is a brief questionnaire that asks questions about your 
mood. This tool is not for diagnostic purposes and the results will not be shared with 
anyone outside the study. Both of these questionnaires are confidential and we ask that 
you not put your name or any other identifying information on them. Completion of both 
items will take approximately thirty minutes. 
When you have completed both items, you may simply return them to us in the self-
addressed postage-paid envelope that came in the same package as the DD-S and the 
CES-D. We ask that you return the envelope no later than January 30, 2009. 
We certainly hope that you will consider completing these surveys, as your answers will 
provide important information about diabetes education and treatment. If you have any 
questions regarding the study, please do not hesitate to contact me at (208) 371-6787. 
Sincerely, 
 
Cynthia Clinkingbeard, MD 
Student, Master of Health Science Program 
College of Health Sciences 
Boise State University 
